0 Replies
Copenhagen, Denmark, April 27th, 2009 As a testimony to the strength of Santaris Pharma’s efficient Drug Discovery Engine, the Company announced today the completion of the delivery of six cancer target drug candidates to their collaboration partner Enzon Pharmaceuticals. All six drug candidates have been designed, synthesized and selected in collaboration... Contine Reading & Discuss→
0 Replies
Santaris Pharma is present with three posters and an oral presentation at the Keystone Meeting from April 25-30, Victoria Canada. Contine Reading & Discuss→
0 Replies
Data on LNA-antimiR®s presented by Santaris Pharma at the American Association for Cancer Research (AACR) 100th Annual Meeting 2009 in Colorado
read more Contine Reading & Discuss→
